Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Articles

Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population

Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Denmark;The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Denmark
Faculty of Health and Medical Sciences, University of Copenhagen, Denmark;Department of Infectious Diseases, Hvidovre Hospital, Copenhagen University Hospital, Denmark
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Denmark;The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Denmark
Vol. 102 No. 8 (2017): August, 2017 https://doi.org/10.3324/haematol.2016.161943

Abstract

In the general population, older age is associated with short leukocyte telomere length and with high risk of infections. In a recent study of allogeneic hematopoietic cell transplantation for severe aplastic anemia, long donor leukocyte telomere length was associated with improved survival in the recipients. These findings suggest that leukocyte telomere length could possibly be a marker of immune competence. Therefore, we tested the hypothesis that shorter leukocyte telomere length is associated with higher risk of infectious disease hospitalization and infection-related death. Relative peripheral blood leukocyte telomere length was measured using quantitative polymerase chain reaction in 75,309 individuals from the general population and the individuals were followed for up to 23 years. During follow up, 9228 individuals were hospitalized with infections and infection-related death occurred in 1508 individuals. Shorter telomere length was associated with higher risk of any infection (hazard ratio 1.05 per standard deviation shorter leukocyte telomere length; 95% confidence interval 1.03–1.07) and pneumonia (1.07; 1.03–1.10) after adjustment for conventional infectious disease risk factors. Corresponding hazard ratios for infection-related death were 1.10 (1.04–1.16) for any infection and 1.11 (1.04–1.19) for pneumonia. Telomere length was not associated with risk of skin infection, urinary tract infection, sepsis, diarrheal disease, endocarditis, meningitis or other infections. In conclusion, our findings indicate that leukocyte telomere length may be a marker of immune competence. Further studies are needed to determine whether risk of infections in allogeneic hematopoietic cell transplantation recipients can be reduced by considering donor leukocyte telomere length when selecting donors.

Introduction

Telomeres are located at the chromosome tips and are composed of protein and tandem repeats of the nucleotide sequence TTAGGG.1 In most cell types, the telomeric DNA becomes shorter with each mitotic cell division due to the end replication problem.32 If telomeres reach a critically short length, further cell divisions may not be possible and cells become senescent or undergo apoptosis.41

In the general population, older age is associated with short telomere length in peripheral blood leukocytes and with high risk of infections,75 but it is currently unknown whether short leukocyte telomere length is a cause of impaired immune competence.8 In a recent study of allogeneic hematopoietic cell transplantation (allo-HCT) for severe aplastic anemia, long donor leukocyte telomere length was associated with improved long-term survival in the recipients.9 Due to insufficient statistical power in the analysis of cause-specific deaths, the study could not identify the reason why survival was higher in patients receiving transplants from donors with long leukocyte telomere length. Since infections are among the leading causes of death in aplastic anemia patients treated with allo-HCT,1110 a possible explanation could be that leukocyte telomere length is a marker of overall immune competence in the donor. However, no previous studies have examined the association between telomere length and risk of hospitalization for infectious disease in the general population, and studies on telomere length and risk of infection-related death have produced conflicting results.1512 If leukocyte telomere length is a marker of overall immune competence in the general population, it would indicate that shortening of telomeres may be one of the biological mechanisms underlying age-related decline in adaptive immunity and increase in infectious disease susceptibility. It is currently unknown whether a marker of immune competence can be useful for making decisions on treatment or other health interventions in individuals from the general population, but such a marker may potentially be useful when selecting donors for allo-HCT. Therefore, examination of the possible association between leukocyte telomere length and immune competence could provide important information of clinical as well as biological relevance.

Given this, we studied 75,309 individuals from the general population to test the hypothesis that shorter telomere length in leukocytes is associated with higher risk of hospitalization for infectious disease and higher risk of infection-related death. All individuals had telomere length measured in peripheral blood leukocytes at study enrollment and the participants were prospectively followed for up to 23 years for hospitalization for infectious disease and death.

Methods

Participants

We studied 75,309 individuals from two studies of the general population: 8681 individuals from the Copenhagen City Heart Study1716 (enrolled between 1991 and 1994) and 66,628 individuals from the Copenhagen General Population Study1918 (enrolled between 2003 and 2012). Using the Danish Civil Registration System,20 which includes a unique identification number for all individuals with permanent residence in Denmark, the participants were randomly invited to represent the general population aged 20–100 years. In the Copenhagen City Heart study, 61% of the invited individuals participated, and in the Copenhagen General Population Study, 46% participated. At the day of examination, all participants completed a questionnaire on lifestyle and health, underwent a physical examination, and had blood samples drawn. None of the individuals participated in both studies. Among the participants, more than 99% were white and of Danish descent. No participants were lost to follow up. The studies were approved by Danish ethical committees and all participants provided written, informed consent.

Covariates

All included covariates were chosen a priori based on previous studies reporting them to be associated with telomere length and risk of infections.242119 Information on age and sex was obtained from the Danish Civil Registration system, while information on smoking status (current/former/never), cumulative smoking in pack-years (with one pack-year defined as 20 cigarettes or equivalent per day for a year), alcohol consumption (none/moderate/heavy, with heavy defined as >168 g/week for men and >84 g/week for women, as recommended by The Danish Health Authority), and body mass index (measured weight in kilograms divided by measured height in meters squared) was derived from the questionnaire and physical examination. As a marker of inflammation, plasma high-sensitivity C-reactive protein level at study enrollment was measured using standard hospital assays.

Telomere length measurements

After isolation of DNA from peripheral blood leukocytes using the Qiagen blood kit,25 relative telomere length was measured by a modified monochrome multiplex quantitative polymerase chain reaction (qPCR) method,26 as previously described in detail elsewhere.2119 The qPCR method was chosen since this is the only available method for high-throughput measurements of telomere length.271 In short, the telomere template was amplified simultaneously with the single copy gene for albumin in the same well to adjust for different amounts of DNA in the samples. All samples were run in quadruplicates. For each sample, we calculated the ratio between telomere (T) repeat copy numbers and single gene (S) copy numbers, and the relative telomere length expressed as the T/S ratio was derived through calibration with measurements on K562 cell line DNA, which was included in each plate. Using this method, the T/S ratio of the K562 cell line DNA is by definition set to 1, so samples with shorter telomere length than K562 cell line DNA have T/S ratios below 1 while samples with longer telomere length than K562 cell line DNA have T/S ratios above 1.26 To obtain a functional single-calibrator measurement, telomere length measurements were adjusted across calibrator lots, as described in detail in the Online Supplementary Methods. The laboratory technician performing all measurements was blinded to infectious disease endpoints and deaths.

Genotypes

An inherent limitation of observational studies on biomarkers and risk of disease is their inability to determine whether a biomarker are having a causal effect on the risk of disease, or if any found associations could be due to confounding or reverse causation. A way of overcoming this limitation is to study whether single nucleotide polymorphisms (SNPs) that influence the level of a biomarker are also associated with risk of disease. Using this approach, we genotyped participants for the three SNPs, rs1317082, rs7726159, and rs2487999, to examine whether a genetic predisposition to shorter telomere length is associated with risk of infections. The 3 SNPs were chosen based on a genome wide association study including 26,089 individuals, which found they were the SNPs most strongly associated with measured leukocyte telomere length.28 The three genotypes were combined into an overall unweighted allele score, taking values from 0 to 6, which was calculated as the sum of the number of telomere length shortening alleles for each of the three genotypes. Since there were only 68 individuals with 0 telomere length shortening alleles, individuals with an unweighted allele score of 0 and 1 were combined into a single group. Similarly, a weighted allele score was constructed by first assigning each SNP a weight according to the SNPs average per allele effect size on measured T/S ratio, and then calculating the sum of weighted telomere shortening alleles for the three SNPs combined. To increase power, genotyping was also performed on participants from the two general population studies for whom measured telomere length was not available, leading to a total of 107,693 individuals genotyped. More details on genotyping are described in the Online Supplementary Methods.

Infectious disease endpoints

Using the national Danish Patient Registry,29 which covers all Danish hospitals, we obtained information for each individual participant on inpatient hospitalizations with a primary discharge diagnosis of an infectious disease from January 1 1977 until November 5 2014. Likewise, we obtained information from the national Danish Patient Registry on emergency room visits with a primary diagnosis of an infectious disease from January 1 1994 until November 5 2014. Information on vital status and date of death until November 5 2014 was retrieved from the Danish Civil Registration system. For participants who died before December 31 2012, information on infection-related deaths was obtained from the national Danish Register of Causes of Death,30 which covers all deaths in Denmark and registers all diagnoses that a physician has listed on the death certificate as contributing to the cause of death. More details on classification of infectious disease endpoints are described in Online Supplementary Table S1 and in the Online Supplementary Methods.

Comorbidities

Non-infectious comorbidities could possibly confound the association between telomere length and risk of infections, since short leukocyte telomere length has been found in individuals with chronic conditions such as heart failure31 and chronic obstructive pulmonary disease,32 and individuals with these conditions are also at high risk of infections.2422 To reduce such confounding, comorbidities at study enrollment were assessed using the Charlson comorbidity index,33 which is a severity weighted measure of comorbid conditions that has been validated for its ability to predict mortality.3534 Individuals at high risk of undiagnosed comorbidities were identified using measurements of white blood cell differential count, platelet count, blood hemoglobin, plasma alanine aminotransferase, plasma creatinine, and non-fasting plasma glucose at study enrollment. These measurements were chosen as a broad screening for hematologic, hepatic, renal, and metabolic diseases. More details on assessment of comorbidities are described in the Online Supplementary Methods.

Statistical analysis

Statistical analyses were performed with Stata v. 13.1. All statistical tests were two-sided. Since several studies have documented a strong association between higher age and shorter telomere length,1965 calculation of telomere length quartiles was adjusted for age by computing quartiles of telomere length separately for each one-year age span. To reduce risk of reverse causation (i.e. that subclinical infections already present at date of examination may influence leukocyte telomere length), individuals were only included in the analyses if they were not hospitalized with any infection during the first 180 days after the date of examination. Risk of infectious disease hospitalization and risk of infection-related death were modeled separately by Cox proportional hazards regression using left-truncated age as the timescale, as described in detail in the Online Supplementary Methods. For the analyses on measured telomere length and risk of hospitalization for infectious disease, and for risk of infection-related death, follow up began 180 days after the date of examination. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort.

Results

Among 75,309 individuals from the general population, older age was strongly associated with shorter leukocyte telomere length with a mean lower T/S ratio of 0.0032 [95% confidence interval (CI): 0.0032–0.0033; linear regression P<110; R-squared=0.073] for each year of older age. Therefore, baseline characteristics are shown after adjustment for age by calculation of age-adjusted quartiles of telomere length (Table 1).

Table 1.Baseline characteristics of 75,309 individuals from the general population according to age-adjusted quartiles of leukocyte telomere length.

Telomere length and risk of infections

During a median follow up of seven years (range 0–23 years), 9228 individuals were hospitalized due to infections. When examining risk of first hospitalization for infection after study enrollment, a one standard deviation shorter leukocyte telomere length was associated with higher risk of any infection [hazard ratio (HR) 1.05; 95%CI: 1.03–1.07] and pneumonia (HR 1.07; 95%CI: 1.03–1.10) (Figure 1). We found no association between telomere length and risk of skin infection, urinary tract infection, sepsis, diarrheal disease, endocarditis, meningitis, or other infections. Similarly, when examining risk of first hospitalization for infection according to age-adjusted quartiles of telomere length, increasing quartiles of telomere length were associated with higher risk of any infection (P for trend=110) and pneumonia (P for trend=310) (Figure 2). Hazard ratios for the shortest versus the longest quartile of telomere length were 1.16 (95%CI: 1.09–1.23) for any infection and 1.25 (95%CI: 1.15–1.36) for pneumonia.

Figure 1.Risk of first hospitalization for any infection and specific infections in the general population per standard deviation shorter telomere length. The sum of specific infections exceeds the number of any infection since some individuals had more than one type of infection. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. CI: confidence interval

Figure 2.Risk of first hospitalization for any infection and pneumonia in the general population according to age-adjusted quartiles of telomere length. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. CI: confidence interval.

When including both first and recurrent infectious disease hospitalizations (Online Supplementary Figure S1), risk estimates per standard deviation shorter telomere length were similar to those from the analysis on risk of first hospitalization for infectious disease (Figure 1).

Stratified analyses on risk of infections

To investigate whether the association between shorter telomere length and higher risk of any infection and pneumonia may be due to reverse causation, we performed stratified analyses according to follow-up interval. We found no indication of reverse causation, as risk estimates for any infection became more pronounced as more time elapsed after study enrollment (P for interaction with follow-up interval=0.006), while risk estimates for pneumonia were largely stable across follow-up intervals (P for interaction with follow-up interval=0.09) (Figure 3).

Figure 3.Risk of first hospitalization for any infection and pneumonia in the general population per standard deviation shorter telomere length stratified according to follow-up interval. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. P for interaction was calculated using a likelihood ratio test, comparing models with and without an interaction term. CI: confidence interval.

To further examine the robustness of the association between shorter telomere length and higher risk of any infection and pneumonia, we performed stratified analyses according to strata of the covariates that were included in the multivariable models (Figure 4 and Online Supplementary Figure S2). To additionally reduce confounding by comorbidities that may be undiagnosed at study enrollment, we also performed stratified analyses according to whether or not participants had normal blood laboratory tests at study enrollment. In all of the above mentioned strata, risk estimates remained stable for any infection (Figure 4) and pneumonia (Online Supplementary Figure S2).

Figure 4.Stratified analyses for risk of first hospitalization for any infection per standard deviation shorter telomere length. Number of individuals at risk and number of infections vary slightly among the stratifications due to varying numbers of individuals with missing data on each of the covariates. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. P for interaction was calculated using a likelihood ratio test, comparing models with and without an interaction term. CI: confidence interval. #Ever smokers only. †>168 g/week for men and >84 g/week for women. §As defined by the Charlson comorbidity index. ‡Defined as any inpatient hospitalization within ten years before study enrollment for any cause other than infections. Includes measurements of white blood cell differential count, platelet count, blood hemoglobin, plasma alanine aminotransferase, plasma creatinine, and non-fasting plasma glucose.

As previous studies have found that shorter telomere length was associated with higher risk of cardiovascular disease,393621 and since cardiovascular disease is associated with high risk of infections,2422 we investigated whether the observed association between shorter telomere length and risk of infections may be secondary to cardiovascular disease. Risk estimates for any infection and pneumonia remained stable when the analyses were stratified according to whether or not individuals were diagnosed with any type of cardiovascular disease at study enrollment or during follow up (Online Supplementary Figure S3). Similarly, risk estimates for any infection and pneumonia were stable when including cardiovascular disease diagnosed at study enrollment or during follow up as a time-dependent variable in the multivariable model (Online Supplementary Figure S4).

Telomere length and risk of infection-related death

One standard deviation shorter telomere length was associated with higher risk of death related to any infection (HR 1.10; 95%CI: 1.04–1.16) and pneumonia (HR 1.11; 95%CI: 1.04–1.19) (Figure 5). We found no association between shorter telomere length and risk of death related to sepsis, urinary tract infection, diarrheal disease, endocarditis, skin infection, or other infections. For meningitis, exact calculations of risk estimates were not possible since there were only 2 meningitis-related deaths. Since previous studies on telomere length and risk of infection-related death have produced conflicting results which could potentially be explained by limited statistical power,1512 we performed power calculations based on the risk estimates from our present study and the number of participants and deaths reported in previous studies (Online Supplementary Table S2). All four previous studies each had less than 15% power to detect a hazard ratio for any infection-related death of 1.10 per standard deviation shorter telomere length at two-sided P<0.05.

Figure 5.Risk of death related to any infection and death related to specific infections in the general population per standard deviation shorter telomere length. The sum of deaths related to specific infections exceeds the number of deaths related to any infection since some individuals had more than one type of infection listed on the death certificate. For meningitis, exact calculations of risk estimates were not possible since there were only 2 meningitis-related deaths. Multivariable models were adjusted for values at study enrollment of age, sex, smoking status, cumulative smoking in pack-years, alcohol consumption, body mass index, plasma C-reactive protein level, Charlson comorbidity index, number of non-infectious disease hospitalizations within ten years before study enrollment, and study cohort. CI: confidence interval.

Genetic predisposition to shorter telomere length and risk of infections

Among the 107,693 genotyped individuals, 21,317 individuals were hospitalized due to any infection during follow up (see Online Supplementary Table S3 for baseline characteristics). Mean T/S ratio decreased by 0.012 (95%CI: 0.011–0.014) per telomere length shortening allele among the 75,018 individuals who had both leukocyte telomere length measurements and genotyping performed (linear regression on telomere length as a function of unweighted allele score: standardized β=−0.076; P=210; R-squared=0.0058; same regression for weighted allele score: standardized β=−0.077; P=610; R-squared=0.0059). For both the unweighted and the weighted allele score, we found no association between a genetic predisposition to shorter telomere length and risk of hospitalization for any infection, pneumonia, skin infection, urinary tract infection, diarrheal disease, sepsis, meningitis, endocarditis or other infections (Online Supplementary Figures S5–S7). Importantly, however, genetic risk estimates did not differ from observational estimates, but as seen from the power calculation in the Online Supplementary Results, the rather modest influence of the SNPs on telomere length leads to very limited power in the analyses on a genetic predisposition to shorter telomeres and risk of infections, despite the large number of individuals genotyped.

Discussion

In this prospective study of 75,309 individuals from the general population, we found that shorter leukocyte telomere length was associated with higher risk of hospitalization due to any infection and pneumonia. Likewise, shorter leukocyte telomere length was associated with higher risk of death related to any infection and pneumonia. Our findings on telomere length and risk of hospitalization for infectious disease are novel, while our findings on risk of infection-related death corroborate the previous studies on this subject, which had produced conflicting results.1512 The higher risk of infections in individuals with shorter leukocyte telomere length could possibly be caused by impaired adaptive immune function as a consequence of short lymphocyte telomere length. This possible mechanism is supported by a study on the immune response after influenza vaccination,40 which found that individuals with long telomere length in B-lymphocytes produced a more robust antibody response when compared to individuals with short B-lymphocyte telomere length. Likewise, when presented with a synthetic influenza peptide in vitro, influenza-specific CD8 T-lymphocytes with long telomere length showed higher proliferative capacity than those with short telomere length.40 This indicates that telomere length in subtypes of lymphocytes may be directly related to the effectiveness of the adaptive immune response. Furthermore, aging leads to increasing numbers of CD8 T-lymphocytes undergoing replicative senescence, and these senescent lymphocytes are characterized by short telomere length and no expression of the co-stimulatory molecule CD28 which is necessary for proliferation.4441 Combined with our results, these findings suggest that shortening of telomeres is likely to be one of the mechanisms underlying age-related decline in adaptive immunity and increased susceptibility to infectious disease.87

Our finding that shorter leukocyte telomere length was associated with higher risk of hospitalization due to any infection and pneumonia is novel, as no previous studies have examined the association between leukocyte telomere length and risk of hospitalization for infectious disease in the general population. Nonetheless, our results are supported by a study on 152 individuals,45 which found that shorter telomere length in peripheral blood mononuclear cells was associated with higher risk of rhinovirus infection in healthy volunteers who were quarantined and experimentally exposed to nasal drops containing rhinovirus. When we investigated risk of specific types of infection, shorter telomere length was associated exclusively with higher risk of pneumonia. However, hazard ratios per standard deviation shorter telomere length was consistently above 1 for skin infection, diarrheal disease, endocarditis and meningitis, although these findings were not statistically significant at a level of P<0.05. Hypothetically, our finding that pneumonia was the only specific type of infection with higher risk in individuals with shorter telomeres could simply be due to the high number of hospitalizations for pneumonia in the general population, leading to more statistical power in the analysis on risk of pneumonia than for other infections. Somewhat similar to our findings, individuals with humoral immunodeficiencies such as X-linked agammaglobulinemia, common variable immunodeficiency, and selective immunoglobulin A deficiency have especially pronounced risk of bacterial respiratory tract infections, often caused by encapsulated bacteria such as Streptococcus pneumoniae and Haemophilus influenzae.46 We did not have information on specific causative pathogens for hospitalizations for pneumonia in the present study, but other studies have found Streptococcus pneumoniae and Haemophilus influenzae to be among the most common causes of bacterial pneumonia in the general population.4847 Hence, the pattern of risk of infectious disease associated with shorter telomere length may to some degree resemble what has been reported for specific deficiencies of the humoral immune response.

Our finding that shorter leukocyte telomere length was associated with higher risk of death related to any infection is supported by two independent prospective cohort studies, which together included a total of 1260 individuals, of whom 83 died from infectious diseases.1312 However, two other prospective cohort studies including a total of 3319 individuals and 90 infectious disease deaths found no association between telomere length and risk of death due to infectious disease.1514 When calculating power based on the risk estimates from our present study and the number of participants and deaths reported in previous studies, the four previous studies each had less than 15% power to detect the risk estimate for any infection-related death found in the present study. This suggests that the conflicting results from previous studies could possibly be related to limited statistical power because of the modest number of deaths from infectious disease in the study populations, which is less of a concern in our present study with 75,309 individuals and 1508 infection-related deaths. Importantly, the precision of the telomere length measurements also affects power, which is especially relevant since studies on telomere length and infection-related death have used different methods for measuring telomere length, and since the precision of the measurements may differ substantially between methods.5049

The results from our study and those from previous studies suggest that leukocyte telomere length may be a marker of overall immune competence in the general population. It is still not known whether such a marker can be useful for making decisions on treatment or other health interventions in individuals from the general population. However, a marker of overall immune competence could potentially be useful when selecting donors for allogeneic hematopoietic cell transplantation (allo-HCT), where infections are among the leading causes of death in the recipients.1110 Theoretically, it may be possible to reduce the risk of serious infections and infection-related death in allo-HCT recipients by including donor telomere length in the selection criteria when selecting donors. Obviously, this hypothesis cannot be tested in a study of the general population, so further studies on donor telomere length and the risk of serious infections and infection-related death in allo-HCT recipients are needed.

Among the strengths of the current study is the prospective general population design, the large number of individuals studied, and the availability of detailed information on possible confounders such as smoking, alcohol intake, body mass index, hospital diagnosed comorbidities, and measurements of C-reactive protein as a marker of inflammation. Furthermore, as we have performed measurements of white blood cell differential count, platelet count, blood hemoglobin, plasma alanine aminotransferase, plasma creatinine, and non-fasting plasma glucose in a large subgroup of 66,818 individuals, we were also able to minimize confounding by undiagnosed comorbidities by stratifying the analyses on whether individuals had normal or abnormal values of these biomarkers. Due to the observational nature of the study, we are unable to determine with any certainty whether the association between leukocyte telomere length and risk of infections are due to a causal effect. In an attempt to investigate the question of causality, we examined the association between a genetic disposition to shorter telomere length and risk of infections in 107,693 individuals genotyped for the three SNPs that were reported to be most strongly associated with leukocyte telomere length in a genome wide association study of 26,089 individuals.28 We found no association between a genetic predisposition to shorter telomere length and risk of any infection or any type of specific infections, which in principle indicates that the observational association between shorter telomere length and higher risk of infections is not due to a causal effect. However, these results should be interpreted with caution, as the rather modest influence of the SNPs on telomere length leads to low statistical power despite the large number of individuals genotyped, and this limits our ability to confirm or disprove any hypotheses of causality. Another limitation of our study is that we only have information on hospitalizations for infectious disease while information on cases of less serious infections that are typically treated by general practitioners is lacking. In theory, our findings could be biased if individuals with short telomere length appear frailer than other individuals, which could lead general practitioners to have a lower threshold for admitting these patients for hospital treatment. However, it is unlikely that our findings are caused solely by such a differential referral bias, as shorter telomere length was also associated with higher risk of death related to any infection and pneumonia.

In conclusion, we prospectively followed 75,309 individuals from the general population for up to 23 years and found that shorter leukocyte telomere length was associated with higher risk of any infection and pneumonia. These findings indicate that leukocyte telomere length may be a marker of immune competence among individuals from the general population. Further studies are needed to determine whether risk of infections in allo-HCT recipients can be reduced by considering donor leukocyte telomere length when selecting donors.

Acknowledgments

We are indebted to laboratory technician Anja Jochumsen for her valuable assistance with the telomere length measurements. We thank the participants and staff of the Copenhagen City Heart Study and the Copenhagen General Population Study for their important contributions.

Footnotes

  • Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures: www.haematologica.org/content/102/8/1457
  • FundingThis work was supported by the Danish Council for Independent Research, the research foundation for health research of the Capital Region of Denmark and by Herlev and Gentofte Hospital, Copenhagen University Hospital.
  • Received December 11, 2016.
  • Accepted May 12, 2017.

References

  1. Bojesen SE. Telomeres and human health. J Intern Med. 2013; 274(5):399-413. PubMedhttps://doi.org/10.1111/joim.12083Google Scholar
  2. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973; 41(1):181-190. PubMedhttps://doi.org/10.1016/0022-5193(73)90198-7Google Scholar
  3. Hills M, Lucke K, Chavez EA, Eaves CJ, Lansdorp PM. Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA). Blood. 2009; 113(23):5765-5775. PubMedhttps://doi.org/10.1182/blood-2009-01-198374Google Scholar
  4. Wang J, Lu X, Sakk V, Klein CA, Rudolph KL. Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood. 2014; 124(22):3237-3240. PubMedhttps://doi.org/10.1182/blood-2014-04-568055Google Scholar
  5. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990; 346(6287):866-868. PubMedhttps://doi.org/10.1038/346866a0Google Scholar
  6. Frenck RW, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA. 1998; 95(10):5607-5610. PubMedhttps://doi.org/10.1073/pnas.95.10.5607Google Scholar
  7. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009; 22(11):1041-1050. PubMedhttps://doi.org/10.1111/j.1432-2277.2009.00927.xGoogle Scholar
  8. Weng NP. Telomeres and immune competency. Curr Opin Immunol. 2012; 24(4):470-475. PubMedhttps://doi.org/10.1016/j.coi.2012.05.001Google Scholar
  9. Gadalla SM, Wang T, Haagenson M. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. JAMA. 2015; 313(6):594-602. PubMedhttps://doi.org/10.1001/jama.2015.7Google Scholar
  10. Robin M, Porcher R, De Castro AR. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Biol Blood Marrow Transplant. 2007; 13(11):1304-1312. PubMedhttps://doi.org/10.1016/j.bbmt.2007.07.007Google Scholar
  11. Wingard JR, Majhail NS, Brazauskas R. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011; 29(16):2230-2239. PubMedhttps://doi.org/10.1200/JCO.2010.33.7212Google Scholar
  12. Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003; 361(9355):393-395. PubMedhttps://doi.org/10.1016/S0140-6736(03)12384-7Google Scholar
  13. Fitzpatrick AL, Kronmal RA, Kimura M. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011; 66(4):421-429. PubMedGoogle Scholar
  14. Martin-Ruiz CM, Gussekloo J, van Heemst D, von Zglinicki T, Westendorp RG. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell. 2005; 4(6):287-290. PubMedhttps://doi.org/10.1111/j.1474-9726.2005.00171.xGoogle Scholar
  15. Njajou OT, Hsueh WC, Blackburn EH. Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2009; 64(8):860-864. PubMedGoogle Scholar
  16. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007; 50(3):549-554. PubMedhttps://doi.org/10.1007/s00125-006-0570-3Google Scholar
  17. Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Bojesen SE. Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 2013; 105(7):459-468. PubMedhttps://doi.org/10.1093/jnci/djt016Google Scholar
  18. Zacho J, Benfield T, Tybjaerg-Hansen A, Nordestgaard BG. Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts. Clin Chem. 2016; 62(2):335-342. PubMedhttps://doi.org/10.1373/clinchem.2015.249680Google Scholar
  19. Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population. J Natl Cancer Inst. 2015; 107(6):djv074. PubMedhttps://doi.org/10.1093/jnci/djv074Google Scholar
  20. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006; 53(4):441-449. PubMedGoogle Scholar
  21. Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Nordestgaard BG. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol. 2012; 32(3):822-829. PubMedhttps://doi.org/10.1161/ATVBAHA.111.237271Google Scholar
  22. Almirall J, Bolibar I, Serra-Prat M. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008; 31(6):1274-1284. PubMedhttps://doi.org/10.1183/09031936.00095807Google Scholar
  23. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J. 1995; 8(10):1694-1698. PubMedhttps://doi.org/10.1183/09031936.95.08101694Google Scholar
  24. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008; 14(11):1041-1047. PubMedhttps://doi.org/10.1111/j.1469-0691.2008.02089.xGoogle Scholar
  25. Scherczinger CA, Bourke MT, Ladd C, Lee HC. DNA extraction from liquid blood using QIAamp. J Forensic Sci. 1997; 42(5):893-896. PubMedGoogle Scholar
  26. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37(3):e21. PubMedhttps://doi.org/10.1093/nar/gkn1027Google Scholar
  27. Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010; 12(12):753-764. PubMedhttps://doi.org/10.1097/GIM.0b013e3181f415b5Google Scholar
  28. Pooley KA, Bojesen SE, Weischer M. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet. 2013; 22(24):5056-5064. PubMedhttps://doi.org/10.1093/hmg/ddt355Google Scholar
  29. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011; 39(7 Suppl):30-33. PubMedhttps://doi.org/10.1177/1403494811401482Google Scholar
  30. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011; 39(7 Suppl):26-29. PubMedhttps://doi.org/10.1177/1403494811399958Google Scholar
  31. van der Harst P, van der Steege G, de Boer RA. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol. 2007; 49(13):1459-1464. PubMedhttps://doi.org/10.1016/j.jacc.2007.01.027Google Scholar
  32. Savale L, Chaouat A, Bastuji-Garin S. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 179(7):566-571. PubMedhttps://doi.org/10.1164/rccm.200809-1398OCGoogle Scholar
  33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-383. PubMedhttps://doi.org/10.1016/0021-9681(87)90171-8Google Scholar
  34. Quan H, Sundararajan V, Halfon P. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43(11):1130-1139. PubMedhttps://doi.org/10.1097/01.mlr.0000182534.19832.83Google Scholar
  35. Quan H, Li B, Couris CM. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173(6):676-682. PubMedhttps://doi.org/10.1093/aje/kwq433Google Scholar
  36. Burnett-Hartman AN, Fitzpatrick AL, Kronmal RA. Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: the Cardiovascular Health Study. Mech Ageing Dev. 2012; 133(5):275-281. PubMedhttps://doi.org/10.1016/j.mad.2012.03.002Google Scholar
  37. Haycock PC, Burgess S, Nounu A. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol. 2017; 3(5):636-651. Google Scholar
  38. Hunt SC, Kimura M, Hopkins PN. Leukocyte telomere length and coronary artery calcium. Am J Cardiol. 2015; 116(2):214-218. PubMedhttps://doi.org/10.1016/j.amjcard.2015.03.060Google Scholar
  39. Scheller MA, Rode L, Nordestgaard BG, Bojesen SE. Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals. Clin Chem. 2016; 62(8):1140-1149. PubMedhttps://doi.org/10.1373/clinchem.2016.258566Google Scholar
  40. Najarro K, Nguyen H, Chen G. Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults. J Infect Dis. 2015; 212(8):1261-1269. PubMedhttps://doi.org/10.1093/infdis/jiv202Google Scholar
  41. Boucher N, Dufeu-Duchesne T, Vicaut E, Farge D, Effros RB, Schachter F. CD28 expression in T cell aging and human longevity. Exp Gerontol. 1998; 33(3):267-282. PubMedhttps://doi.org/10.1016/S0531-5565(97)00132-0Google Scholar
  42. Chou JP, Effros RB. T cell replicative senescence in human aging. Curr Pharm Des. 2013; 19(9):1680-1698. PubMedGoogle Scholar
  43. Effros RB. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine. 2007; 25(4):599-604. PubMedhttps://doi.org/10.1016/j.vaccine.2006.08.032Google Scholar
  44. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol. 1996; 156(10):3587-3590. PubMedGoogle Scholar
  45. Cohen S, Janicki-Deverts D, Turner RB. Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA. 2013; 309(7):699-705. PubMedhttps://doi.org/10.1001/jama.2013.613Google Scholar
  46. Furst DE. Serum immunoglobulins and risk of infection: how low can you go¿. Semin Arthritis Rheum. 2009; 39(1):18-29. PubMedhttps://doi.org/10.1016/j.semarthrit.2008.05.002Google Scholar
  47. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987; 1(8534):671-674. PubMedhttps://doi.org/10.1016/S0140-6736(87)90430-2Google Scholar
  48. Jokinen C, Heiskanen L, Juvonen H. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis. 2001; 32(8):1141-1154. PubMedhttps://doi.org/10.1086/319746Google Scholar
  49. Verhulst S, Susser E, Factor-Litvak PR. Response to: Reliability and validity of telomere length measurements. Int J Epidemiol. 2016; 45(4):1298-1301. PubMedhttps://doi.org/10.1093/ije/dyw194Google Scholar
  50. Verhulst S, Susser E, Factor-Litvak PR. Commentary: The reliability of telomere length measurements. Int J Epidemiol. 2015; 44(5):1683-1686. PubMedhttps://doi.org/10.1093/ije/dyv166Google Scholar

Article Information

Vol. 102 No. 8 (2017): August, 2017 : Articles
 
DOI
https://doi.org/10.3324/haematol.2016.161943
Pubmed
28522577
Pubmed Central
PMC5541879
 
Published
2017-08-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 

Article Usage

Online Views
2070
PDF Downloads
332

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online